BerGenBio ASA: Share capital increase
Bergen, Norway, 3 February 2022 - Reference is made to the stock exchange notice published by BerGenBio ASA (the "Company") (OSE: BGBIO) on 27 January 2022 where the Company announced that the board of directors of the Company had resolved to increase the Company's share capital in connection with the exercise of options pursuant to the Company's share option program. A total of 100,000 options were exercised and 100,000 new shares were issued at an average subscription price of NOK 15.33 per share. The share capital increase has been duly registered in the Norwegian Register of Business